Table 3

Results of clinical trials at time T+4 weeks

Patient	RDI	Central %	ESSS	SaO₂%	TCO₂	MSLT
1	1.8	100	6	92	41	12
2	1.5	100	7	92	40	12
3	2.1	100	6	92.5	40	11
4	3	100	14	91	42	9.25
5	1.8	100	5	93	41	10
6	4	100	15	90	42	13
7	1	100	4	93	41	15
8	1	100	5	94	42	14
9	1.2	100	3	94.5	41	14.25
10	0.7	100	4	93	41	14.5
11	1.7	100	5	94	41	13
12	1.5	100	5	92	40	13.5
13	1.3	100	7	91	41	12
14	—	—	—	—	—	—
15	2	100	9	96	40	8.5
16	2.7	100	5	92	40	10.5
17	1	100	5	92	41	14
18	1	100	3	92	40	14.25
19	1.2	100	6	91	41	11.25
20	1	100	5	90	40	15
Mean	1.66	100	5.59	92.4	40.8	12.47
SD	1.00	0	2.00	1.4	1.1	1.97